Newark, Delaware, December 17, 2025 – Molecular Imaging Services, LLC (MIS), a leader in turnkey molecular imaging solutions, is pleased to announce a strategic partnership with JPC Nuclear Technologies (JPC). Under this new alignment, JPC will operate under the MIS umbrella, expanding the combined organizations’ reach and service capabilities.

JPC, founded in 2013 by Jason Vanover, CNMT, is a privately held nuclear medicine services provider headquartered in Annapolis, Maryland. Today, JPC operates more than 20 SPECT imaging programs across the tri-state region and has built a strong reputation for quality, efficiency, and clinical excellence.

“This partnership with Jason and the JPC team marks an exciting opportunity to expand our PET/CT offerings into the markets JPC currently serves,” said Frank DiGregorio, Founder, Managing Partner, CEO. “We are confident that combining our strengths will enhance our collective capabilities and reinforce our commitment to delivering high-quality diagnostic imaging services.”

As part of the partnership, MIS is pleased to appoint Jason Vanover as President of MIS’s JPC Nuclear Division. MIS also welcomes the entire JPC staff as valued members of the organization.

“We are thrilled to join forces with MIS,” said Jason. “Together, we will bring even greater value, expanded services, and improved patient outcomes to the clients and communities we serve.”

MIS and JPC look forward to building on their shared mission, continuing to deliver exceptional service, and expanding access to advanced molecular imaging technologies across the region.

About Molecular Imaging Services, LLC (MIS)

MIS is a leading provider of turnkey molecular imaging solutions, specializing in the development, implementation, and management of PET/CT and SPECT imaging programs. MIS supports healthcare organizations with comprehensive operational, clinical, and regulatory expertise to ensure seamless and effective imaging service delivery.

About JPC Nuclear Technologies (JPC)

JPC is a trusted provider of nuclear medicine services founded in 2013 by Jason Vanoy, CNMT. The company operates more than 20 SPECT programs throughout the tri-state region, delivering reliable, patient-centered imaging solutions.